AGN 6.67% 77.0¢ argenica therapeutics limited

Ann: Phase 1 Clinical Trial Summary, page-25

  1. sle
    10,762 Posts.
    lightbulb Created with Sketch. 344
    Hmmmm! Three I hold including AGN are presenting here.

    The Argenica team are going to AusBioInvest 2022, are you? The programme for Australia’s largest life sciences investment conference launched last week, and we are so excited to be presenting in October!Learn more here:
    https://bit.ly/3dokFO2
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.